Standing out in a crowd

Historically a manufacturer of generic and branded-generic products, Upsher-Smith was poised to introduce its first in a line of branded epilepsy drugs. Our charge was twofold: build pre-launch credibility for the unmet needs of current therapy, and increase share of mind among prescribers in a CNS space that was already saturated with well-entrenched competitors.

  • Fingerpaint is Agency of the Year according to MedAdNews

Compelling content play

We created EPILOG—a peer-to-peer forum that sparked dialog about unmet needs in epilepsy treatment. Original content co-created by key opinion leaders was used to attract the interest of neurologists. Within a year, the site was on Google’s radar and actively engaged 30% of the target audience.